Literature DB >> 3757164

The effect of food on the oral administration of 6-mercaptopurine.

N K Burton, M J Barnett, G W Aherne, J Evans, I Douglas, T A Lister.   

Abstract

The effect of food on the bioavailability of 6-mercaptopurine (6-MP) has been investigated. Seven patients were studied on two separate occasions. On the first occasion 6-MP was administered p.o. after an overnight fast and on the second, 15 min after a standard breakfast. 6-MP concentrations were determined by high-performance liquid chromatography. Variable plasma drug levels were observed between individual subjects in the fasting state. The peak levels of 6-MP were lower and took longer to be achieved following administration after a standard breakfast than after an overnight fast. In two subjects levels were undetectable (less than 20 ng/ml). In view of these observations it is suggested that 6-MP should be administered before food if maximum blood levels are to be achieved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757164     DOI: 10.1007/bf00253074

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  Food, drugs, and bioavailability.

Authors:  C F George
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

2.  A novel method for the quantitation of 6-mercaptopurine in human plasma using high-performance liquid chromatography with fluorescence detection.

Authors:  N K Burton; G W Aherne; V Marks
Journal:  J Chromatogr       Date:  1984-08-10

3.  6-mercaptopurine: pharmacokinetics in animals and preliminary results in children.

Authors:  T J Schouten; R A De Abreu; C H De Bruyn; E Van der Kleijn; M J Oosterbaan; E D Schretlen; G A De Vaan
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

4.  Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

Authors:  S Zimm; J M Collins; R Riccardi; D O'Neill; P K Narang; B Chabner; D G Poplack
Journal:  N Engl J Med       Date:  1983-04-28       Impact factor: 91.245

5.  Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia.

Authors:  L Lennard; C A Rees; J S Lilleyman; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

6.  Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma.

Authors:  A G Bosanquet; E D Gilby
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Small intestinal transit time affects methotrexate absorption in children with acute lymphoblastic leukemia.

Authors:  A D Pearson; A W Craft; E J Eastham; G W Aherne; P Littleton; G L Pearson; A N Campbell
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  7 in total
  9 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

Authors:  Wendy Landier; Lindsey Hageman; Yanjun Chen; Nancy Kornegay; William E Evans; Bruce C Bostrom; Jacqueline Casillas; David S Dickens; Anne L Angiolillo; Glen Lew; Kelly W Maloney; Leo Mascarenhas; A Kim Ritchey; Amanda M Termuhlen; William L Carroll; Mary V Relling; F Lennie Wong; Smita Bhatia
Journal:  J Clin Oncol       Date:  2017-03-24       Impact factor: 44.544

4.  Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia.

Authors:  P Lafolie; O Björk; S Hayder; L Ahström; C Peterson
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

5.  6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations.

Authors:  D L Lancaster; N Patel; L Lennard; J S Lilleyman
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

6.  Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.

Authors:  P Lafolie; S Hayder; O Björk; C Peterson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 7.  Interaction between cytostatics and nutrients.

Authors:  R Henriksson; K O Rogo; K Grankvist
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 8.  Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.

Authors:  Hannah K Batchelor
Journal:  Children (Basel)       Date:  2015-06-09

Review 9.  Advances in Thiopurine Drug Delivery: The Current State-of-the-Art.

Authors:  Ahmed B Bayoumy; Femke Crouwel; Nripen Chanda; Timothy H J Florin; Hans J C Buiter; Chris J J Mulder; Nanne K H de Boer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-09-06       Impact factor: 2.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.